What are the key differences between WIPO ST.25 and the new sequence rules for applications filed after July 1, 2022?

The MPEP 2420 indicates a significant change in the rules governing sequence disclosures in patent applications filed on or after July 1, 2022. The section states:

“[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP §§ 2412 – 2419 for applications filed on or after July 1, 2022.]”

While the specific differences are not detailed in this section, it’s clear that new rules apply for more recent applications. The key differences likely involve updated standards for sequence listings, possibly reflecting advancements in biotechnology and bioinformatics. For detailed information on the new rules, applicants should refer to MPEP §§ 2412 – 2419, which cover the requirements for applications filed on or after July 1, 2022.

To learn more:

Topics: MPEP 2400 - Biotechnology, Patent Law, Patent Procedure
Tags: amino acid sequences, biotechnology patents, nucleotide sequences, patent applications, Sequence Rules, wipo st.25